U.S.
states seek $26.4 billion from drug firms in opioid
litigation: WSJ
Send a link to a friend
[August 18, 2020]
(Reuters) - U.S. states are seeking a
combined $26.4 billion from three major drug distributors and Johnson &
Johnson <JNJ.N> to settle opioid litigation against the companies, the
Wall Street Journal reported on Tuesday, citing people familiar with the
matter.
|
About a dozen attorneys general are seeking a collective $21.14
billion from the distributors, which include McKesson Corp <MCK.N>,
Amerisourcebergen <ABC.N> and Cardinal Health <CAH.N>, and $5.28
billion from J&J, the WSJ reported https://www.wsj.com/articles/states-seek-26-4-billion-from-drug-companies-in-opioid-litigation-11597743000?mod=searchresults&page=1&pos=2.
The companies did not immediately respond to Reuters' requests for
comment.
[to top of second column] |
The lawsuits accuse drugmakers of overstating the benefits of opioids while
downplaying the risks and allege distributors failed to flag and halt a rising
tide of suspicious orders.
A closely watched opioid trial pitting New York state against McKesson, Johnson
& Johnson and others was postponed in March due to the coronavirus outbreak.
(Reporting by Manas Mishra in Bengaluru; Editing by Anil D'Silva)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |